Our company

BIOCAPX is a technology-driven investment platform providing investors easy access to curated institutional-grade biotech deals, while empowering investors through:

  • An asset centric investing model
  • Increased risk mitigation
  • Potentialfor early liquidity

Our current focus is the execution of phase I & II clinical trial programs. By digitizing the drug-discovery process, we are able to connect all participants of theecosystem; for a holistic and streamlined approach to investing and developing assets.

Our central mission is to accelerate drug discovery while providing broader investor groups high quality biotech deals that deliver returns.